108 related articles for article (PubMed ID: 19534619)
1. Disturbed expression of type 1 iodothyronine deiodinase splice variants in human renal cancer.
Piekielko-Witkowska A; Master A; Wojcicka A; Boguslawska J; Brozda I; Tanski Z; Nauman A
Thyroid; 2009 Oct; 19(10):1105-13. PubMed ID: 19534619
[TBL] [Abstract][Full Text] [Related]
2. Alternative splicing of iodothyronine deiodinases in pituitary adenomas. Regulation by oncoprotein SF2/ASF.
Piekielko-Witkowska A; Kedzierska H; Poplawski P; Wojcicka A; Rybicka B; Maksymowicz M; Grajkowska W; Matyja E; Mandat T; Bonicki W; Nauman P
Biochim Biophys Acta; 2013 Jun; 1832(6):763-72. PubMed ID: 23462647
[TBL] [Abstract][Full Text] [Related]
3. Alternative splicing of the adenylyl cyclase stimulatory G-protein G alpha(s) is regulated by SF2/ASF and heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) and involves the use of an unusual TG 3'-splice Site.
Pollard AJ; Krainer AR; Robson SC; Europe-Finner GN
J Biol Chem; 2002 May; 277(18):15241-51. PubMed ID: 11825891
[TBL] [Abstract][Full Text] [Related]
4. MiR-224 targets the 3'UTR of type 1 5'-iodothyronine deiodinase possibly contributing to tissue hypothyroidism in renal cancer.
Boguslawska J; Wojcicka A; Piekielko-Witkowska A; Master A; Nauman A
PLoS One; 2011; 6(9):e24541. PubMed ID: 21912701
[TBL] [Abstract][Full Text] [Related]
5. Restoration of type 1 iodothyronine deiodinase expression in renal cancer cells downregulates oncoproteins and affects key metabolic pathways as well as anti-oxidative system.
Popławski P; Wiśniewski JR; Rijntjes E; Richards K; Rybicka B; Köhrle J; Piekiełko-Witkowska A
PLoS One; 2017; 12(12):e0190179. PubMed ID: 29272308
[TBL] [Abstract][Full Text] [Related]
6. Disturbed expression of splicing factors in renal cancer affects alternative splicing of apoptosis regulators, oncogenes, and tumor suppressors.
Piekielko-Witkowska A; Wiszomirska H; Wojcicka A; Poplawski P; Boguslawska J; Tanski Z; Nauman A
PLoS One; 2010 Oct; 5(10):e13690. PubMed ID: 21082031
[TBL] [Abstract][Full Text] [Related]
7. Identification of two novel splicing variants of human type II iodothyronine deiodinase mRNA.
Ohba K; Yoshioka T; Muraki T
Mol Cell Endocrinol; 2001 Feb; 172(1-2):169-75. PubMed ID: 11165050
[TBL] [Abstract][Full Text] [Related]
8. ASF/SF2-like maize pre-mRNA splicing factors affect splice site utilization and their transcripts are alternatively spliced.
Gao H; Gordon-Kamm WJ; Lyznik LA
Gene; 2004 Sep; 339():25-37. PubMed ID: 15363843
[TBL] [Abstract][Full Text] [Related]
9. Kinetics and thiol requirements of iodothyronine 5'-deiodination are tissue-specific in common carp (Cyprinus carpio L.).
Klaren PH; Geven EJ; Nagelkerke A; Flik G
Comp Biochem Physiol B Biochem Mol Biol; 2012 Mar; 161(3):275-82. PubMed ID: 22198122
[TBL] [Abstract][Full Text] [Related]
10. Effect of 3,5,3'-Triiodothyronine (T3) administration on dio1 gene expression and T3 metabolism in normal and type 1 deiodinase-deficient mice.
Maia AL; Kieffer JD; Harney JW; Larsen PR
Endocrinology; 1995 Nov; 136(11):4842-9. PubMed ID: 7588215
[TBL] [Abstract][Full Text] [Related]
11. Short communication: quantitative comparison of iodothyronine deiodinase I and II mRNA expression in ovine tissues.
Foroughi MA; Dehghani H
Res Vet Sci; 2013 Dec; 95(3):891-3. PubMed ID: 23916591
[TBL] [Abstract][Full Text] [Related]
12. The second RNA-binding domain of the human splicing factor ASF/SF2 is the critical domain controlling adenovirus E1A alternative 5'-splice site selection.
Dauksaite V; Akusjärvi G
Biochem J; 2004 Jul; 381(Pt 2):343-50. PubMed ID: 15068396
[TBL] [Abstract][Full Text] [Related]
13. Induction of type 1 iodothyronine deiodinase expression inhibits proliferation and migration of renal cancer cells.
Poplawski P; Rybicka B; Boguslawska J; Rodzik K; Visser TJ; Nauman A; Piekielko-Witkowska A
Mol Cell Endocrinol; 2017 Feb; 442():58-67. PubMed ID: 27940296
[TBL] [Abstract][Full Text] [Related]
14. Spatio-temporal expression of the trans-acting splicing factors SF2/ASF and heterogeneous ribonuclear proteins A1/A1B in the myometrium of the pregnant human uterus: a molecular mechanism for regulating regional protein isoform expression in vivo.
Pollard AJ; Sparey C; Robson SC; Krainer AR; Europe-Finner GN
J Clin Endocrinol Metab; 2000 May; 85(5):1928-36. PubMed ID: 10843177
[TBL] [Abstract][Full Text] [Related]
15. Untranslated regions of thyroid hormone receptor beta 1 mRNA are impaired in human clear cell renal cell carcinoma.
Master A; Wójcicka A; Piekiełko-Witkowska A; Bogusławska J; Popławski P; Tański Z; Darras VM; Williams GR; Nauman A
Biochim Biophys Acta; 2010 Nov; 1802(11):995-1005. PubMed ID: 20691260
[TBL] [Abstract][Full Text] [Related]
16. Placental iodothyronine deiodinase expression in normal and growth-restricted human pregnancies.
Chan S; Kachilele S; Hobbs E; Bulmer JN; Boelaert K; McCabe CJ; Driver PM; Bradwell AR; Kester M; Visser TJ; Franklyn JA; Kilby MD
J Clin Endocrinol Metab; 2003 Sep; 88(9):4488-95. PubMed ID: 12970328
[TBL] [Abstract][Full Text] [Related]
17. The structure of the coding and 5'-flanking region of the type 1 iodothyronine deiodinase (dio1) gene is normal in a patient with suspected congenital dio1 deficiency.
Toyoda N; Kleinhaus N; Larsen PR
J Clin Endocrinol Metab; 1996 Jun; 81(6):2121-4. PubMed ID: 8964838
[TBL] [Abstract][Full Text] [Related]
18. VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma.
Bates DO; Cui TG; Doughty JM; Winkler M; Sugiono M; Shields JD; Peat D; Gillatt D; Harper SJ
Cancer Res; 2002 Jul; 62(14):4123-31. PubMed ID: 12124351
[TBL] [Abstract][Full Text] [Related]
19. T cell signaling abnormalities in systemic lupus erythematosus are associated with increased mutations/polymorphisms and splice variants of T cell receptor zeta chain messenger RNA.
Nambiar MP; Enyedy EJ; Warke VG; Krishnan S; Dennis G; Wong HK; Kammer GM; Tsokos GC
Arthritis Rheum; 2001 Jun; 44(6):1336-50. PubMed ID: 11407693
[TBL] [Abstract][Full Text] [Related]
20. Selenium-dependent pre- and posttranscriptional mechanisms are responsible for sexual dimorphic expression of selenoproteins in murine tissues.
Riese C; Michaelis M; Mentrup B; Götz F; Köhrle J; Schweizer U; Schomburg L
Endocrinology; 2006 Dec; 147(12):5883-92. PubMed ID: 16959840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
